A proinflammatory role for IL-18 in rheumatoid arthritis

J. Alastair Gracie(University of Strathclyde), Iain B. McInnes(University of Glasgow), Kristy Kennedy(University of Glasgow), Robert Carter(University of London), Bernard P. Leung, Max Field(University of Glasgow), Damo Xu(Shenzhen University), Rosalyn Forsey(University of Glasgow), Morag R. Greer(University of Glasgow), Xiaoqing Wei, Foo Y. Liew(University of Glasgow), Woon Ling Chan(University of London), Ashley Gilmour(University of Glasgow), Alan K. Foulis(University of Glasgow)
Journal of Clinical Investigation
November 15, 1999
10.1172/jci7317
Cited by 648

Related Papers

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK
|The Lancet|2023|838
The signal pathways and treatment of cytokine storm in COVID-19
|Signal Transduction and Targeted Therapy|2021|615
Interleukin-18
|Journal of Leukocyte Biology|2003|600